Macquarie Group’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$270K Sell
5,162
-1,404
-21% -$84.3K ﹤0.01% 746
2025
Q4
$386K Sell
6,566
-1,824,428
-100% -$111M ﹤0.01% 761
2025
Q3
$102M Buy
1,830,994
+33,408
+2% +$1.79M 0.12% 218
2025
Q2
$92.5M Sell
1,797,586
-270,053
-13% -$13.6M 0.11% 255
2025
Q1
$121M Sell
2,067,639
-116,140
-5% -$7.87M 0.15% 186
2024
Q4
$157M Sell
2,183,779
-310,655
-12% -$22.8M 0.19% 133
2024
Q3
$199M Sell
2,494,434
-18,705
-0.7% -$1.41M 0.22% 102
2024
Q2
$180M Sell
2,513,139
-20,534
-0.8% -$1.51M 0.21% 115
2024
Q1
$178M Buy
2,533,673
+21,801
+0.9% +$1.56M 0.2% 120
2023
Q4
$194M Buy
2,511,872
+41,221
+2% +$2.72M 0.22% 105
2023
Q3
$168M Buy
2,470,651
+350,299
+17% +$27.7M 0.21% 118
2023
Q2
$173M Buy
2,120,352
+164,437
+8% +$13.2M 0.2% 127
2023
Q1
$145M Buy
1,955,915
+323,246
+20% +$24.9M 0.17% 154
2022
Q4
$135M Buy
1,632,669
+120,493
+8% +$9.57M 0.16% 162
2022
Q3
$107M Buy
1,512,176
+8,320
+0.6% +$719K 0.13% 206
2022
Q2
$130M Sell
1,503,856
-38,132
-2% -$3.57M 0.15% 173
2022
Q1
$167K Buy
1,541,988
+109,164
+8% +$11.3M 0.13% 174
2021
Q4
$185M Buy
1,432,824
+10,420
+0.7% +$1.28M 0.15% 165
2021
Q3
$172M Sell
1,422,404
-25,464
-2% -$3.1M 0.15% 171
2021
Q2
$163M Buy
1,447,868
+1,272,580
+726% +$134M 0.13% 179
2021
Q1
$16.7M Sell
175,288
-264,148
-60% -$24.1M 0.02% 589
2020
Q4
$34.9M Sell
439,436
-9,268
-2% -$671K 0.05% 388
2020
Q3
$27.8M Sell
448,704
-34,636
-7% -$2.25M 0.05% 387
2020
Q2
$31.9M Sell
483,340
-3,756
-0.8% -$225K 0.05% 359
2020
Q1
$23.1M Sell
487,096
-24,704
-5% -$1.24M 0.05% 382
2019
Q4
$28.1M Buy
511,800
+24,176
+5% +$1.27M 0.04% 422
2019
Q3
$23.9M Sell
487,624
-24,712
-5% -$1.24M 0.04% 415
2019
Q2
$26.7M Sell
512,336
-142,724
-22% -$7.19M 0.05% 387
2019
Q1
$32.5M Sell
655,060
-48,472
-7% -$2.18M 0.06% 354
2018
Q4
$25.5M Sell
703,532
-15,164
-2% -$633K 0.05% 372
2018
Q3
$36.7M Buy
718,696
+17,592
+3% +$779K 0.06% 337
2018
Q2
$25.9M Sell
701,104
-85,668
-11% -$3.27M 0.04% 425
2018
Q1
$29.7M Buy
786,772
+16,284
+2% +$575K 0.05% 366
2017
Q4
$25M Sell
770,488
-29,752
-4% -$945K 0.04% 421
2017
Q3
$24.2M Buy
800,240
+26,252
+3% +$779K 0.04% 417
2017
Q2
$22.7M Sell
773,988
-943,112
-55% -$25.8M 0.04% 419
2017
Q1
$43.6M Buy
1,717,100
+57,140
+3% +$1.47M 0.08% 219
2016
Q4
$42.7M Sell
1,659,960
-736
-0% -$19.3K 0.08% 207
2016
Q3
$45.5M Sell
1,660,696
-7,442,888
-82% -$204M 0.09% 190
2016
Q2
$257M Buy
9,103,584
+4,303,188
+90% +$111M 0.25% 77
2016
Q1
$113M Buy
4,800,396
+2,392
+0% +$52.7K 0.23% 85
2015
Q4
$108M Buy
4,798,004
+129,184
+3% +$2.95M 0.22% 87
2015
Q3
$108M Sell
4,668,820
-10,568
-0.2% -$265K 0.23% 87
2015
Q2
$115M Buy
4,679,388
+800
+0% +$20K 0.23% 88
2015
Q1
$117M Sell
4,678,588
-1,260
-0% -$30K 0.23% 90
2014
Q4
$108M Sell
4,679,848
-100,552
-2% -$2.3M 0.22% 94
2014
Q3
$112M Sell
4,780,400
-402,564
-8% -$9.44M 0.24% 93
2014
Q2
$120M Sell
5,182,964
-2,423,792
-32% -$53.6M 0.27% 86
2014
Q1
$162M Buy
7,606,756
+55,888
+0.7% +$1.26M 0.28% 84
2013
Q4
$179M Buy
7,550,868
+55,148
+0.7% +$1.2M 0.32% 77
2013
Q3
$150M Sell
7,495,720
-71,556
-0.9% -$1.36M 0.29% 82
2013
Q2
$131M Buy
+7,567,276
New +$126M 0.29% 82

Other funds holding TECH

Macquarie Group's TECH Position: Q1 2026 in Review

Macquarie Group reduced its Bio-Techne (TECH) stake by 21% in Q1 2026, selling an estimated $84.3K and leaving 5,162 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #746.

Macquarie Group first reported a position in TECH in Q2 2013 and has held it in 52 quarters since. The position peaked at $257M in Q2 2016. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Macquarie Group held 5,162 shares of Bio-Techne worth $270K as of Q1 2026.
  • Macquarie Group sold 1,404 Bio-Techne shares in Q1 2026, an estimated $84.3K.
  • Bio-Techne made up ﹤0.01% of Macquarie Group's portfolio in Q1 2026, its #746 holding.
  • Macquarie Group first reported a position in Bio-Techne in Q2 2013 and has held it in 52 quarters since.
  • Macquarie Group's Bio-Techne position peaked at $257M in Q2 2016.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.